ISPOR - EE249 Cost and Outcomes of Teduglutide in Adult Patients With Short Bowel Syndrome—Is the Combination With BSC Cost-Effective for the Society?

EE249 Cost and Outcomes of Teduglutide in Adult Patients With Short Bowel Syndrome—Is the Combination With BSC Cost-Effective for the Society?

Abstract

Authors

E. Walter C. Dawoud E. Hütterer F. Harpain

Full Text Cite This Article

Back to Volume 26, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now